049960 Stock Chart & Stats
₩14850.00
-₩110.00(-0.74%)
―
--
Day’s Range― - ―
52-Week Range₩11,350.00 - ₩18,500.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)11.28K
Market Cap
₩102.38B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.6
Beta0.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,400,000
10 Day Avg. Volume10,540
30 Day Avg. Volume11,279
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
049960 FAQ
What was Cell Biotech Co., Ltd’s price range in the past 12 months?
Cell Biotech Co., Ltd lowest stock price was ₩11350.00 and its highest was ₩18500.00 in the past 12 months.
What is Cell Biotech Co., Ltd’s market cap?
Cell Biotech Co., Ltd’s market cap is ₩102.38B.
When is Cell Biotech Co., Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cell Biotech Co., Ltd’s earnings last quarter?
Cell Biotech Co., Ltd released its earnings results on May 08, 2026. The company reported ₩781.984 earnings per share for the quarter, beating the consensus estimate of N/A by ₩781.984.
Is Cell Biotech Co., Ltd overvalued?
According to Wall Street analysts Cell Biotech Co., Ltd’s price is currently Undervalued.
Does Cell Biotech Co., Ltd pay dividends?
Cell Biotech Co., Ltd does not currently pay dividends.
What is Cell Biotech Co., Ltd’s EPS estimate?
Cell Biotech Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cell Biotech Co., Ltd have?
Cell Biotech Co., Ltd has 9,400,000 shares outstanding.
What happened to Cell Biotech Co., Ltd’s price movement after its last earnings report?
Cell Biotech Co., Ltd reported an EPS of ₩781.984 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.72%.
Which hedge fund is a major shareholder of Cell Biotech Co., Ltd?
Currently, no hedge funds are holding shares in KR:049960
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Genexine, Inc.
―
T&R Biofab Co., Ltd
―
ViGenCell, Inc.
―
Vaxcell-Bio Therapeutics
―
Celemics, Inc.
―